ADDENDUM TO: NIAID PROGRAM ANNOUNCEMENT PA-01-113

RELEASE DATE:  December 19, 2003

NOTICE:  NOT-AI-04-014

National Institute of Allergy and Infectious Diseases (NIAID)

This is to clarify that this Program Announcement, PA-01-113, THERAPEUTICS 
RESEARCH ON AIDS-ASSOCIATED OPPORTUNISTIC INFECTIONS AND MALIGNANCIES that 
appeared in the NIH Guide on June 28, 2001 at 
https://grants.nih.gov/grants/guide/pa-files/PA-01-113.html will continue to 
be accepted by the National Cancer Institute and National Institute of Dental 
and Craniofacial Research.

The Division of AIDS (DAIDS) of the National Institute of Allergy and 
Infectious Diseases (NIAID) will no longer participate in this Program
Announcement, PA-01-113.
 
The final receipt date for applications to NIAID was September 1, 2003. 

However this PA does not expire until May 2, 2004.

INQUIRIES

Kenneth Cremer, PhD
Division of Cancer Biology
National Cancer Institute
Room 5016
6130 Executive Boulevard, MSC 7398
Bethesda, MD  20892-7398
Telephone:  301-496-6085
FAX:  301-496-2025
Email:  kc47i@nih.gov

Dennis F. Mangan, Ph.D.
Division of Extramural Research
National Institute of Dental and Craniofacial Research
Building 45, Room 4AN-32F, MSC 6402
Bethesda, MD  20892-6402
Telephone:  301-594-2421
FAX:  301-480-8318
Email:  dennis.mangan@nih.gov

The National Heart, Lung, and Blood Institute (NHLBI) has an interest in
supporting research on the pulmonary, cardiovascular and hematologic aspects 
of opportunistic infections associated with HIV infection.  Therefore, 
applications of interest are likely to be given a may be primary or secondary  
assignment to NHLBI in accordance with the NIH referral guidelines.  
Inquiries regarding NHLBI programmatic issues may be directed to:

Hannah H. Peavy, M.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Suite 10018, MSC 7952
Bethesda, MD  20892-7952
Telephone:  301-435-0222
FAX:  301-480-3557
Email:  hannah_peavy@nih.gov

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 
has an interest in supporting research on the influence of opportunistic 
pathogens on the enterocytes in the gastrointestinal tract as well as the 
hepatocytes in the liver in liver disease expression.  Therefore, 
applications of interest are likely to be given a may be primary or secondary 
assignment to NIDDK in accordance with the NIH referral guidelines.  
Inquiries regarding NIDDK programmatic issues may be directed to:

Frank A. Hamilton, M.D., Ph.D.
Chief, Digestive Diseases Program Branch
Room 6AN12B
DDDN/NIDDK
Natcher Building 45
45 Center Drive, MSC 6600
Bethesda, MD  20892-6600
Telephone:  301-594-8877
FAX:  301-480-8300
Email:  hamiltonf@extra.niddk.nih.gov

For other applications, please note the following:

Program Officers in the Complications and Co-Infections Research Branch, 
DAIDS may be contacted at (301) 435-3769 or through the NIAID/DAIDS website, 
http://www.niaid.nih.gov/ncn/staff/contactdaids.htm#ccib. 

At any time, potential applicants can obtain a current listing of 
active NIAID PAs on the NIAID WWW site at URL:
http://www.niaid.nih.gov/ncn/budget/pas.htm

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.